Tenecteplase Fails to Boost EVT Outcomes - Top-Institutions - MDSpire

Tenecteplase Fails to Boost EVT Outcomes

Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.

  • By

  • Kathryn Wighton

  • May 14, 2026

  • 6 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Beijing Tiantan Hospital, Capital Medical University
    Beijing Tiantan Hospital, Capital Medical University

    Beijing, Beijing

    Key Differentiators

    • Neurology

  • #2

    Qilu Hospital of Shandong University
    Qilu Hospital of Shandong University

    Jinan, Shandong

    Key Differentiators

    • Neurology

  • #3

    Heidelberg University Hospital
    Heidelberg University Hospital

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Neurology

Original Source(s)

Tenecteplase Fails to Boost EVT Outcomes

  • by Kathryn Wighton

  • May 14, 2026

Related Content

The effect of probiotic supplements on cognitive outcomes and neuroplasticity in elderly ischemic stroke survivors

Elevated NHHR at admission is independently associated with elevated post-stroke depressive symptoms

Modified small vessel disease score as the top predictor of stroke outcome after thrombectomy: a CT-based machine learning study